Incyte
INCY
#1110
Rank
NZ$34.83 B
Marketcap
NZ$177.46
Share price
2.05%
Change (1 day)
39.33%
Change (1 year)

Incyte (INCY) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$2.90 Billion

According to Incyte's latest financial reports the company's total liabilities are NZ$2.90 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Incyte - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$3.54 B40.61%
2023-12-31NZ$2.51 B8.68%
2022-12-31NZ$2.31 B36.02%
2021-12-31NZ$1.70 B29.41%
2020-12-31NZ$1.31 B7.01%
2019-12-31NZ$1.22 B14.62%
2018-12-31NZ$1.07 B13.42%
2017-12-31NZ$0.94 B-46.24%
2016-12-31NZ$1.75 B44.04%
2015-12-31NZ$1.22 B9.03%
2014-12-31NZ$1.12 B11.95%
2013-12-31NZ$1.00 B62.96%
2012-12-31NZ$0.61 B-13.77%
2011-12-31NZ$0.71 B-4.94%
2010-12-31NZ$0.74 B-33.19%
2009-12-31NZ$1.12 B43.66%
2008-12-31NZ$0.78 B37.43%
2007-12-31NZ$0.56 B-8.72%
2006-12-31NZ$0.62 B8.12%
2005-12-31NZ$0.57 B-6.29%
2004-12-31NZ$0.61 B77.34%
2003-12-31NZ$0.34 B-27.39%
2002-12-31NZ$0.47 B-25.33%
2001-12-31NZ$0.63 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
NZ$139.38 B 4,695.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.91 B-68.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$157.66 B 5,324.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$200.16 B 6,786.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
NZ$0.55 B-81.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
NZ$0.57 B-80.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$108.25 B 3,624.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
NZ$0.12 B-95.69%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
NZ$0.23 B-91.80%๐Ÿ‡บ๐Ÿ‡ธ USA